Health & Medicine
-
Swiss Brain Implants Restore Paralyzed Man’s Walking
May 24, 2023 — infopulsetoday.com — A groundbreaking medical breakthrough has been achieved by Swiss scientists, who have successfully enabled a paralyzed…
-
NHS Rolls Out Glofitamab for Aggressive Lymphoma After Just One Prior Treatment
Diffuse large B‑cell lymphoma progresses rapidly and can infiltrate lymph nodes, spleen, liver, and bone marrow. For many patients whose disease returns…
-
Epcoritamab approved in US for large B-cell lymphoma
United States, May 22, 2023 — cybernewschronicle.com — Epcoritamab, a novel Bi-specific T-cell engager (BiTE) therapy, has marked a significant milestone in…
-
Europe Clears Ivosidenib for Acute Myeloid Leukemia Five Years After US Launch
Ivosidenib, marketed under the brand name Tibsovo, has marked a significant milestone in the treatment of certain types of cancer, including acute…
-
WHO Lifted COVID-19 Global Emergency Status on May 5, 2023, After More Than Three Years
The World Health Organization has officially ended the global emergency status for COVID-19, marking a formal conclusion to a crisis that began…
-
Pfizer’s Paxlovid Cuts COVID Hospitalization Risk by 88%
A recent analysis of Pfizer’s oral antiviral Paxlovid indicates that it can lower the chance of hospitalization or death by 88% among…
-
WHO Declares COVID-19 Over as a Global Health Emergency After More Than Three Years
The World Health Organization ended COVID-19’s global health emergency designation on May 15, 2023, but this official step does not mark the…
-
Federal Registry Tracks Firefighter Cancer to Find Prevention Methods Nationwide
For decades, firefighters have faced a grim reality: the very substances they encounter while battling blazes can trigger cancer years later. Benzene,…
-
Enzalutamide Plus Hormone Therapy Cuts Death Risk 40.3% in Recurrent Prostate Cancer
In April 2023 the European Union authorized a fixed‑dose combination that merges two anticancer agents into a single tablet for the treatment…
-
Ghana First to Approve New Oxford Malaria Vaccine for Young Children
The Food and Drugs Authority in Ghana has granted approval for the R21/Matrix‑M malaria vaccine to be administered to children between five…
-
European Commission Approves Niraparib and Abiraterone Tablet for BRCA-Mutated Metastatic Prostate Cancer
European Union, April 19, 2023 — cybernewschronicle.com — Niraparib/abiraterone acetate, a fixed-dose combination anti-cancer medication, has been approved for the treatment of…
-
CAR-T Cell Therapy Expands Toward Autoimmune Disease, Infections and Off-the-Shelf Designs
As of April 15, 2023, cancer treatment research continues to progress through developments in engineered chimeric antigen receptor (CAR)-T cell delivery. This…
-
Equatorial Guinea Declares First Marburg Outbreak After Nine Deaths in Kie-Ntem Province
/ HTML. Word count 450-560 words. We must not invent anything. Use only facts from source. Let’s list facts: – Virus kills…
-
NIOSH Opens National Firefighter Cancer Registry
United States, April 15, 2023 — cybernewschronicle.com — On April 15, 2023, the National Firefighter Registry for Cancer opened its doors to…
-
Tanzania Reports First-Ever Outbreak of Marburg Virus Disease
Health authorities in Tanzania have officially confirmed an outbreak of Marburg virus disease, marking the first time the East African nation has…
-
Marburg Virus Outbreak Confirmed in Tanzania for First Time Ever
On 21 March 2023, Tanzania’s Ministry of Health officially declared an outbreak of Marburg virus disease, turning the nation from a Marburg‑free…
-
How Motivational Interviewing Supports Neurodivergent People
MANILA, June 23 — As communities across Asia continue to grow and learn together, a powerful approach to helping others is gaining…
-
Equatorial Guinea Confirms First Marburg Virus Outbreak After Deaths in Kie-Ntem Province
A disease outbreak has been reported in Equatorial Guinea, with the first cases emerging on February 7, 2023. The outbreak was identified…
-
South Africa’s Cholera Outbreak Reaches Five Provinces, 31 Dead, as Hammanskraal Water Fails
The cholera outbreak first identified on 1 February 2023 is now pressing South Africa’s public‑health capacity in ways that could have lasting…
-
US Approves New Gene Therapy For Bladder Cancer Treatment
In December 2022 the U.S. Food and Drug Administration granted approval to nadofaragene firadenovec, sold under the brand name Adstiladrin, marking the…
-
FDA Approves Adstiladrin, First Gene Therapy for BCG-Unresponsive Bladder Cancer
United States, December 20, 2022 — cybernewschronicle.com — Nadofaragene firadenovec, a gene therapy marketed under the brand name Adstiladrin, has been approved…
-
Mirati Wins FDA OK for KRAS Lung Cancer Pill Krazati
San Diego, December 18, 2022 — infopulsetoday.com — For decades, the KRAS gene was considered undruggable. A single mutation in it drives…
-
FDA Approves Pluvicto for Advanced Prostate Cancer Treatment
A radiopharmaceutical known as Lutetium (177Lu) vipivotide tetraxetan has become available for patients with a specific form of advanced prostate cancer following…
-
FDA Grants Accelerated Approval to Elahere for FRalpha-Positive Platinum-Resistant Ovarian Cancer
The U.S. Food and Drug Administration granted approval on November 15, 2022, to Mirvetuximab soravtansine, a new medication marketed as Elahere, for…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992